David McIntyre

Chief Financial Officer, HeartWare International, Inc.

Companies

Inhibikase Therapeutics, Inc.Chief financial officer Apr 16, 2025 to now¹
Avita MedicalChief financial officer Jul 10, 2020 to Jul 21, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibikase Therapeutics, Inc. IKT10,285 shares³$18.8K at $1.83Apr 16, 2025

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibikase Therapeutics, Inc., Chief financial officer
2
SEC EDGARAvita Medical, Chief financial officer
3
SEC EDGARInhibikase Therapeutics, Inc. shares after the filing of Apr 16, 2025